Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02637856
Brief Title: A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)

First Submitted : December 18, 2015
First Submitted that Met QC Criteria : December 18, 2015
First Posted : December 22, 2015 (Estimate)

Results First Submitted : April 15, 2020
Results First Submitted that Met QC Criteria : May 8, 2020
Results First Posted : May 26, 2020

Last Update Submitted that Met QC Criteria : May 8, 2020
Last Update Posted : May 26, 2020